Press release
Health Protection Agency welcomes the Approval of ERWINAZE™ Biologics License Application for Treatment of Acute Lymphoblastic Leukemia
December 7, 2011Manufacturing and Production
Salisbury, UK – 18th November 2011 –the Health Protection Agency (HPA) today welcomed the news that the U.S. Food and …
Actelion Pharmaceuticals Takes to the Cloud with Global Deployment of Veeva CRM and iRep
December 5, 2011BARCELONA, Spain – 1 December, 2011 – Before selecting cloud-based Veeva CRM for 500+ users worldwide, Actelion Ltd. had been …
Changes to the EMA’s registration process for SMEs
November 22, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates
The European Medicines Agency (EMA) has recently made changes to its process for the registration of micro, small or medium-sized …
Update on the planned consolidation of UK medicines legislation
November 21, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Earlier this year we reported on progress in the consolidation of the UK medicines legislation and that the Medicines and …
Autoclave Design Flexibility is Feature of Priorclave Stand at Medica1
November 9, 2011Manufacturing and Production
Visitors to the Priorclave stand 1E02 can evaluate first-hand the benefits of models including:
TranslatePharma now partnered with European Regulatory Solutions
November 8, 2011As a part of the ERA Consultancy Group, European Regulatory Solutions (ERS) specialise in offering consultancy services and regulatory advice …
Risk Based Inspections for good pharmacovigilance practice
October 24, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Recently in the UK there has been a move towards risk-based inspection programmes. The scope, frequency and depth of MHRA …
TranslateMedia listed in Deloitte UK Technology Fast 50 for 2011
October 24, 2011The Deloitte UK Technology Fast 50 was founded in 1998, and remains one of Britain’s foremost technology programs. The program …
Medical Devices: Harmonisation of Requirements for Address of Manufacturer
October 19, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The inclusion of the manufacturer’s address on the labels and instructions for use is an Essential Requirement according to the …
Opportunity to Realise the Value of Dormant UK Authorisations before December Deadline
October 19, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Holders wishing to cancel their authorisations, registrations and licences are required to notify the MHRA by 31 December 2011 to …
Stallergenes Moves to the Cloud with Veeva CRM
October 11, 2011BARCELONA, SPAIN — 11 October, 2011 – Stallergenes, the world leader in sublingual immunotherapy, has selected Veeva CRM to replace …
Latest Priorclave Compact Autoclave Design to
October 7, 2011Manufacturing and Production
Despite this comprehensive range of laboratory autoclaves there is always someone who wants something different and that is exactly what …
PRIORCLAVE AUTOCLAVES SHIP OUT EARLY TO AFRICA
October 7, 2011Manufacturing and Production
The order called for a total of seventy-two top-loading, 150L capacity steam sterilisers with high output/low power steam generators built-in. …
SHL receives Good Design Award for Molly Auto Injector
October 3, 2011Manufacturing and Production auto injector, autoinjector, good design award, molly
SHL Group is honored to have recently received certification for the Good Design Award for its revolutionary auto injector, Molly. …
Chiltern expands North American Operation with a new office in Illinois
September 30, 2011Research and Development
Mr. Barry Simms, Chiltern’s Country Manager, North America, commented, “Chiltern continues to look for opportunities to increase our strategic footprint …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
